Ananda Pharma Plc (AQU:ANA)
London · Delayed Price · Currency is GBP · Price in GBX 0.3050
0.00 (0.00%)
At close: Jul 11, 2025
Ananda Pharma Company Description
Ananda Pharma Plc, together with its subsidiaries, invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally.
The company provides cannabinoid-based medicines for the treatment of chronic inflammatory pain conditions.
It also grows melon and root tubers; develops and distributes health products; wholesales pharmaceutical goods; manufactures and sells organic basic and essential oils; and is involved in crop production activities.
The company was formerly known as Ananda Developments Plc and changed its name to Ananda Pharma Plc in December 2024.
Ananda Pharma Plc was incorporated in 2018 and is based in London, the United Kingdom.
Ananda Pharma Plc
| Country | United Kingdom |
| Founded | 2018 |
| Industry | Pharmaceutical Preparations |
| Employees | 12 |
| CEO | Melissa Sturgess |
Contact Details
Address: 60 Gracechurch Street London, EC3V 0HR United Kingdom | |
| Website | anandadevelopments.com |
Stock Details
| Ticker Symbol | ANA |
| Exchange | Aquis Exchange |
| Fiscal Year | February - January |
| Reporting Currency | GBP |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Melissa Sturgess | Chief Executive Officer |
| Jeremy Sturgess-Smith | Chief Financial Officer |